Your browser doesn't support javascript.
loading
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases.
Marmorino, Federica; Prisciandaro, Michele; Giordano, Mirella; Ortolan, Elisa; Crucitta, Stefania; Manca, Paolo; Antoniotti, Carlotta; Valenti, Marta Maria; Danesi, Romano; Conca, Veronica; Mazzoli, Giacomo; Boccaccino, Alessandra; Carullo, Martina; Martinetti, Antonia; Sottotetti, Elisa; Masi, Gianluca; Sposito, Carlo; Zaffaroni, Nadia; Milione, Massimo; Fontanini, Gabriella; Del Re, Marzia; Pietrantonio, Filippo; Cremolini, Chiara.
  • Marmorino F; Unit of Oncology, University Hospital of Pisa, Pisa, Italy.
  • Prisciandaro M; Department of Translational Research and New Technologies in Medicine and Surgery, University Hospital of Pisa, University of Pisa, Pisa, Italy.
  • Giordano M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ortolan E; Unit of Oncology, University Hospital of Pisa, Pisa, Italy.
  • Crucitta S; Department of Translational Research and New Technologies in Medicine and Surgery, University Hospital of Pisa, University of Pisa, Pisa, Italy.
  • Manca P; Department of Applied Research and Technological Development, National Cancer Institute of Milan, Milan, Italy.
  • Antoniotti C; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Valenti MM; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Danesi R; Unit of Oncology, University Hospital of Pisa, Pisa, Italy.
  • Conca V; Department of Translational Research and New Technologies in Medicine and Surgery, University Hospital of Pisa, University of Pisa, Pisa, Italy.
  • Mazzoli G; Department of Applied Research and Technological Development, National Cancer Institute of Milan, Milan, Italy.
  • Boccaccino A; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Carullo M; Unit of Oncology, University Hospital of Pisa, Pisa, Italy.
  • Martinetti A; Department of Translational Research and New Technologies in Medicine and Surgery, University Hospital of Pisa, University of Pisa, Pisa, Italy.
  • Sottotetti E; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Masi G; Unit of Oncology, University Hospital of Pisa, Pisa, Italy.
  • Sposito C; Department of Translational Research and New Technologies in Medicine and Surgery, University Hospital of Pisa, University of Pisa, Pisa, Italy.
  • Zaffaroni N; Unit of Oncology, University Hospital of Pisa, Pisa, Italy.
  • Milione M; Department of Translational Research and New Technologies in Medicine and Surgery, University Hospital of Pisa, University of Pisa, Pisa, Italy.
  • Fontanini G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Del Re M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pietrantonio F; Unit of Oncology, University Hospital of Pisa, Pisa, Italy.
  • Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University Hospital of Pisa, University of Pisa, Pisa, Italy.
JCO Precis Oncol ; 6: e2200244, 2022 11.
Article en En | MEDLINE | ID: mdl-36356286

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Colon / ADN Tumoral Circulante / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Colon / ADN Tumoral Circulante / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article